But implantation with KYSE30 could significantly increase FGFR2+ BM cells, which was rapidly decreased to basal level after tumor removal, indicating that FGFR2+ cells in BM could be mobilized by active tumors (Fig. 1B). The gene discussed is FGFR2; the disease is neoplasm.